Related Experiment Video
Updated: May 12, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery
Published on: June 7, 2024
Neonatal small extracellular vesicle-loaded GelNB hydrogel reprograms the vascular-immune microenvironment for spinal
Feifei Yuan1,2,3, Chaoran Shi1,2,4, Xisong Liang5
1Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South University, Changsha, China.
Abstract:
Adult mammals with spinal cord injury (SCI) face permanent disability from failed regeneration and scarring, while neonatal mice achieve scarless repair. We show neonatal mouse circulating blood-derived small extracellular vesicles (NCE) rejuvenate adult spinal cord microvascular endothelial cells (SCMECs), restoring lipid metabolism, easing immune imbalance, and supporting neuroaxonal regrowth. Post-SCI myelin debris triggers IRS1-mediated PI3K-Akt-mTOR overactivation in SCMECs, causing harmful lipid droplet buildup, organelle dysfunction, and endothelial-to-mesenchymal transition (EndoMT). It also increases CXCL12 secretion from SCMECs, which recruits CXCR4+ macrophages. These macrophages release TNF-α and GDF15, promoting neuronal injury and EndoMT, and forming a destructive feedback loop. We create a "Microenvironment-Reprogramming Potent Hydrogel" - a high-adhesion GelNB hydrogel loaded with NCE - as an efficient delivery tool. NCE targetedly deliver miR-487b-3p to block IRS1 and CXCL12, breaking the vicious cycle. This remodels microvasculature, normalizes SCMEC lipid metabolism, reduces macrophage infiltration, promotes neuroregeneration, and achieves functional recovery. Our study uncovers an endothelium-immune crosstalk axis hindering SCI repair and highlights miR-487b-3p-rich sEVs as a promising therapy.

